Kaneka Eurogentec Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
475
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
1
Kaneka Eurogentec General Information
Description
Operator of a biotechnology company focused on life science research, diagnostics and the production of novel therapies. The company uses coupling strategies to offer tailor-made life science products such as peptides, proteins, assay kits and plasmids for DNA vaccines, thereby helping the healthcare industry in the formulation of biopharmaceutical gene therapies and reagents.
Contact Information
Website
www.eurogentec.com(Operating Subsidiary)
Corporate Office
- Liege science park
- 5, Rue Bois Saint-Jean
- 4102 Seraing
- Belgium
Corporate Office
- Liege science park
- 5, Rue Bois Saint-Jean
- 4102 Seraing
- Belgium
Kaneka Eurogentec Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kaneka Eurogentec Comparisons
Industry
Financing
Details
Kaneka Eurogentec Competitors (11)
One of Kaneka Eurogentec’s 11 competitors is Promega, a Formerly PE-Backed company based in Madison, WI.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Promega | Formerly PE-Backed | Madison, WI | ||||
| Allele Life Sciences Private | Corporation | Noida, India | ||||
| Molecular Biology Resources | Accelerator/Incubator Backed | Milwaukee, WI | ||||
| Bio-Techne | Corporation | Minneapolis, MN | ||||
| Vipragen Biosciences | Venture Capital-Backed | Bengaluru, India |
Kaneka Eurogentec Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kaneka Eurogentec Patents
Kaneka Eurogentec Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7935981-B2 | Method for producing plasmid dna using e. coli | Active | 16-Jul-2021 | ||
| EP-4372095-A1 | Method for producing plasmid dna using escherichia coli | Pending | 16-Jul-2021 | ||
| EP-4372095-A4 | Method for producing plasmid dna using escherichia coli | Pending | 16-Jul-2021 | ||
| US-20240318166-A1 | Method for producing plasmid dna using escherichia coli | Pending | 16-Jul-2021 | ||
| WO-2023286629-A1 | Method for producing plasmid dna using escherichia coli | Inactive | 16-Jul-2021 | C12N15/102 |
Kaneka Eurogentec Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kaneka Eurogentec Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kaneka Eurogentec Acquisitions (1)
Kaneka Eurogentec’s most recent deal was a Merger/Acquisition with AnaSpec. The deal was made on 23-Oct-2009.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AnaSpec | 23-Oct-2009 | Merger/Acquisition | Drug Discovery |
Kaneka Eurogentec Affiliates
Subsidiaries (3)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Eurogentec Proteomics | Koln, Germany | 1993 | |
| AnaSpec | Fremont, CA | 1993 | |
| Societe Europeenne De Biotechnologie En Abrege Eurogentec Fr | Angers, France | 1989 |
Kaneka Eurogentec FAQs
-
When was Kaneka Eurogentec founded?
Kaneka Eurogentec was founded in 1985.
-
Where is Kaneka Eurogentec headquartered?
Kaneka Eurogentec is headquartered in Seraing, Belgium.
-
What is the size of Kaneka Eurogentec?
Kaneka Eurogentec has 475 total employees.
-
What industry is Kaneka Eurogentec in?
Kaneka Eurogentec’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Kaneka Eurogentec a private or public company?
Kaneka Eurogentec is a Private company.
-
What is the current valuation of Kaneka Eurogentec?
The current valuation of Kaneka Eurogentec is .
-
What is Kaneka Eurogentec’s current revenue?
The current revenue for Kaneka Eurogentec is .
-
How much funding has Kaneka Eurogentec raised over time?
Kaneka Eurogentec has raised $2.24M.
-
Who are Kaneka Eurogentec’s investors?
BNP Paribas Capital Partners, Isatis Capital, Matignon Investissement et Gestion, Privast Capital Partners, and University of Liege have invested in Kaneka Eurogentec.
-
Who are Kaneka Eurogentec’s competitors?
Promega, Allele Life Sciences Private, Molecular Biology Resources, Bio-Techne, and Vipragen Biosciences are some of the 11 competitors of Kaneka Eurogentec.
-
When was Kaneka Eurogentec acquired?
Kaneka Eurogentec was acquired on 31-Jul-2010.
-
Who acquired Kaneka Eurogentec?
Kaneka Eurogentec was acquired by Kaneka.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
